Relationship between Expression of Cellular Receptor-27.8 kDa and Lymphocystis Disease Virus (LCDV) Infection

Ronghua Wu1, Xiaoqian Tang1, Xiuzhen Sheng1

  • 1Laboratory of Pathology and Immunology of Aquatic Animals, Ocean University of China, 5 Yushan Road, Qingdao 266003, P. R. China.

Plos One
|May 30, 2015
PubMed

Insights

Lymphocystis disease virus (LCDV) infection up-regulates a 27.8 kDa membrane receptor (27.8R) in fish cells. Blocking this receptor with antibodies inhibits viral replication and cell damage, revealing a key host-pathogen interaction.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • A 27.8 kDa membrane protein in flounder gill (FG) cells was identified as a potential receptor for lymphocystis disease virus (LCDV).
  • Understanding the interaction between LCDV and its cellular receptor is crucial for comprehending viral pathogenesis.

Purpose of the Study:

  • To investigate the expression of the 27.8 kDa receptor (27.8R) and LCDV loads in FG and hirame natural embryo (HINAE) cells.
  • To determine the effect of anti-27.8R monoclonal antibodies (MAbs) on LCDV infection and receptor expression.

Main Methods:

  • Quantification of 27.8R expression and LCDV copies in FG and HINAE cells via infection and MAb treatment.
  • Confocal microscopy to assess co-localization of 27.8R and LCDV.
  • Evaluation of cytopathic effects post-infection and MAb intervention.

Main Results:

  • 27.8R is expressed on the cell surface and co-localizes with LCDV in both cell types.
  • LCDV infection induces dose-dependent up-regulation of 27.8R, with expression peaking before viral load.
  • Anti-27.8R MAbs significantly reduced 27.8R up-regulation, LCDV copies, and cytopathic effects.

Conclusions:

  • LCDV infection triggers the up-regulation of the 27.8R, enhancing cellular susceptibility to viral entry.
  • The 27.8R plays a critical role in facilitating LCDV infection and replication.
  • Targeting the 27.8R with antibodies presents a potential strategy for controlling LCDV infections.